| Clinical study "common" name (formal title) | Number of enrollees (per protocol [PP]/intent-to-treat [ITT]) | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year completed | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| VAULT (Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy) | 48 patients | Bayer/Pusan National University Hospital NCT01950741 | 2015 | Lee JE, Shin JP, Kim HW, et al. Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study. Graefes Arch Clin Exp Ophthalmol. 2017; 255(3):493-502. https://link.springer.com/article/10.1007%2Fs00417-016-3489-5 |
|